Nchroma Bio

nChroma Bio is a genetic medicines company developing durable in vivo therapies by pairing best-in-class genetic cargoes, including epigenetic editing approaches, with targeted delivery technologies for diseases of significant unmet need. Headquartered at 201 Brookline Avenue in Boston, Massachusetts, the company is backed by DCVC and GV. This is a corporate research and therapeutics organization; as of this enrichment pass it publishes no public developer API, documentation portal, SDKs, or machine-readable API surface.

Nchroma Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Genetic Medicines, Epigenetic Editing, and Therapeutics.

Nchroma Bio’s developer surface includes engineering blog, support, and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

7.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyBiotechnologyGenetic MedicinesEpigenetic EditingTherapeuticsLife SciencesDrug Discovery

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 7.6/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.2 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/nchroma-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: nchroma-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/nchroma-bio.png
name: Nchroma Bio
description: nChroma Bio is a genetic medicines company developing durable in vivo therapies by pairing best-in-class genetic
  cargoes, including epigenetic editing approaches, with targeted delivery technologies for diseases of significant unmet
  need. Headquartered at 201 Brookline Avenue in Boston, Massachusetts, the company is backed by DCVC and GV. This is a corporate
  research and therapeutics organization; as of this enrichment pass it publishes no public developer API, documentation portal,
  SDKs, or machine-readable API surface.
url: https://raw.githubusercontent.com/api-evangelist/nchroma-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Genetic Medicines
- Epigenetic Editing
- Therapeutics
- Life Sciences
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/nchroma-bio-domain-security.yml
- type: Website
  url: https://www.nchromabio.com
- type: Blog
  url: https://www.nchromabio.com/news-research/
- type: PrivacyPolicy
  url: https://www.nchromabio.com/privacy-policy/
- type: Support
  url: https://www.nchromabio.com/contact-us/
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1